Andus T - Search Results

1

Zils K, Bielack S, Wilhelm M, Werner M, Schwarz R, Windhager R, Hofmann-Wackersreuther G, Andus T, Kager L, Kuehne T, Reichardt P, von Kalle T. Zils K, et al. Among authors: andus t. Ann Oncol. 2013 Aug;24(8):2190-5. doi: 10.1093/annonc/mdt154. Epub 2013 Apr 23. Ann Oncol. 2013. PMID: 23613478 Free article.

2

1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes.

Gross V, Andus T, Tran-Thi TA, Schwarz RT, Decker K, Heinrich PC. Gross V, et al. Among authors: andus t. J Biol Chem. 1983 Oct 25;258(20):12203-9. J Biol Chem. 1983. PMID: 6226656 Free article.

3

Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.

Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A, Ewe K, Schölmerich J; German/Austrian Budesonide Study Group. Andus T, et al. Dig Dis Sci. 2003 Feb;48(2):373-8. doi: 10.1023/a:1021900115403. Dig Dis Sci. 2003. PMID: 12643618 Clinical Trial.

4

Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.

Andus T, Kocjan A, Müser M, Baranovsky A, Mikhailova TL, Zvyagintseva TD, Dorofeyev AE, Lozynskyy YS, Cascorbi I, Stolte M, Vieth M, Dilger K, Mohrbacher R, Greinwald R; International Salofalk Suppository OD Study Group. Andus T, et al. Inflamm Bowel Dis. 2010 Nov;16(11):1947-56. doi: 10.1002/ibd.21258. Inflamm Bowel Dis. 2010. PMID: 20310020 Clinical Trial.

5

Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.

Hammond A, Andus T, Gierend M, Ecker KW, Scholmerich J, Herfarth H; German Budesonide Foam Study Group. Hammond A, et al. Among authors: andus t. Hepatogastroenterology. 2004 Sep-Oct;51(59):1345-9. Hepatogastroenterology. 2004. PMID: 15362749 Clinical Trial.

6

Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma.

Barth C, Bosse A, Andus T. Barth C, et al. Among authors: andus t. Z Gastroenterol. 2005 Oct;43(10):1129-32. doi: 10.1055/s-2005-858626. Z Gastroenterol. 2005. PMID: 16220452

7

Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.

Shipkova M, Franz J, Abe M, Klett C, Wieland E, Andus T. Shipkova M, et al. Among authors: andus t. Ther Drug Monit. 2011 Jun;33(3):321-8. doi: 10.1097/FTD.0b013e31821a7c34. Ther Drug Monit. 2011. PMID: 21544018

8

Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures.

Andus T, Geiger T, Hirano T, Kishimoto T, Tran-Thi TA, Decker K, Heinrich PC. Andus T, et al. Eur J Biochem. 1988 Apr 15;173(2):287-93. doi: 10.1111/j.1432-1033.1988.tb13997.x. Eur J Biochem. 1988. PMID: 2452086 Free article.

9

Induction of alpha 1-acid glycoprotein by recombinant human interleukin-1 in rat hepatoma cells.

Geiger T, Andus T, Klapproth J, Northoff H, Heinrich PC. Geiger T, et al. Among authors: andus t. J Biol Chem. 1988 May 25;263(15):7141-6. J Biol Chem. 1988. PMID: 3259230 Free article.

10

Synthesis of alpha 2-macroglobulin in rat hepatocytes and in a cell-free system.

Andus T, Gross V, Tran-Thi TA, Heinrich PC. Andus T, et al. FEBS Lett. 1983 Jan 10;151(1):10-4. doi: 10.1016/0014-5793(83)80331-7. FEBS Lett. 1983. PMID: 6186524 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page